PT THERAGNOSTIC BV -  

Ranking results:

Past rankings:

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 3
As coordinator: 0
As participant: 1
Sole participant: 2
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2017 147.213 5.994.176 459.713 1 1
2015 2.427.594 0 2.427.594 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ACADEMISCH ZIEKENHUIS MAASTRICHT1
CENTRE OSCAR LAMBRET1
CLINIQUES UNIVERSITAIRES SAINTLUC1
DANMARKS TEKNISKE UNIVERSITET1
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
EUROPEAN CANCER PATIENT COALITION1
HEALTH INNOVATION VENTURES BV1
KATHOLIEKE UNIVERSITEIT LEUVEN1
PHILOGEN1
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS1
STICHTING KATHOLIEKE UNIVERSITEIT1
TECHNISCHE UNIVERSITAET DRESDEN1
UNIVERSITA CATTOLICA DEL SACRO CUORE1
UNIVERSITAIR ZIEKENHUIS GENT1
UNIVERSITEIT MAASTRICHT1
UNIVERSITY COLLEGE LONDON1

Constancy:

Total number of partners: 16
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 16
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2017-11-17Optimising Radiomics for MRI-based personalised cancer treatment REACTcoordinator147.2131
2017-01-01Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer IMMUNOSABRparticipant5.994.17617
2015-06-01Radiomics of lung cancer (RAIL): non-invasive stratification of tumour heterogeneity for personalised cancer therapy RAILcoordinator2.427.5941